Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

Oligonucleotide Backbone Modifications

Ziel

Therapeutic oligonucleotides are rapidly emerging as novel modalities for the treatment of several previously unaddressable diseases. The development of oligonucleotide therapeutics has thereby been significantly driven by chemical modifications that enhance nuclease resistance, pharmacokinetic properties, and target engagement. Especially the modification of the phosphorus site at the internucleoside linkage, in particular by the replacement of an oxygen with sulfur in the form of phosphorothioates, proved to be decisively beneficial. However, despite the immense and immediate impact, the current phosphorus backbone chemistry to form modified functionalities, such as phosphonates and phosphoramidates, remained severely limited by the classical reactivity at phosphorus. Expanding the chemical space of oligonucleotide backbone modifications requires transformations that can operate under mild conditions compatible with sensitive nucleic acid substrates. Here, we propose to explore the innovation potential of an unusually versatile method for oligonucleotide backbone modification developed in the framework of an ERC-CoG funded project. With the intellectual property protected by the filing of four patent applications, this Proof of Concept project aims to explore a stereoselective library creation by the divergent synthetic backbone modification platform. The method already allows linear and parallel synthesis from commercially available nucleosides via standard phosphoramidite synthesis and avoids the purification of sensitive intermediates. Efforts in this PoC will be focussed on diastereoselective oligonucleotide backbone modifications, the corresponding IP protection, licensing of the innovation as part of research collaborations with the pharmaceutical industry, and the creation of a spinout company.

Wissenschaftliches Gebiet (EuroSciVoc)

Programm/Programme

Thema/Themen

Finanzierungsplan

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) ERC-2026-POC

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Gastgebende Einrichtung

UNIVERSITAT BASEL
Netto-EU-Beitrag
€ 150 000,00
Adresse
PETERSPLATZ 1
4051 Basel
Schweiz
Region
Schweiz/Suisse/Svizzera Nordwestschweiz Basel-Stadt
Aktivitätstyp
Higher or Secondary Education Establishments
Links
Gesamtkosten
Keine Daten

Begünstigte (1)